+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Inflation Device Market by Display Type (Analog & Digital), Capacity (20ml, 30ml, 60ml), Application (Interventional Cardiology, Radiology, Peripheral Vascular, Urology), End User (Hospitals & Clinics, Ambulatory Surgery Centers) - Forecasts to 2024

  • PDF Icon

    Report

  • 138 Pages
  • April 2019
  • Region: Global
  • Markets and Markets
  • ID: 4763822

The global inflation devices market is projected to grow at a CAGR of 4.7% during the forecast period

The global inflation devices market is projected to reach USD 600 Million by 2024 from USD 480 Million in 2019, at a CAGR of 4.7% from 2019 to 2024. The increasing incidence of target diseases, favorable medical reimbursement for minimally invasive procedures in developed countries, rising demand of minimally invasive surgical procedures across major countries, and increasing applications of inflation devices are the key factors driving the growth of inflation devices market. Government initiatives to control the burden of healthcare-associated infections (HAI) in developed countries and increasing healthcare expenditure across emerging markets are further assisting market growth.

The analog inflation devices segment accounted for the largest market share of global inflation devices market in 2018

Based on display type, the inflation devices market is segmented into analog and digital display inflation devices. The analog display inflation devices segment is expected to account for larger share of inflation devices market in 2019. The large share of this segment is attributed to the reluctance among users for adopting advanced display techniques and low cost and portability of analog inflation devices as compared to digital inflation devices.

The interventional cardiology application segment accounted for the largest share of the inflation devices market in 2018

Based on application, interventional cardiology, interventional radiology, peripheral vascular procedures, urological procedures, gastroenterological procedures, and other applications. The interventional cardiology application segment is estimated to command the largest share of the inflation devices market in 2018. The large share of this segment is attributed to the growing prevalence of cardiovascular diseases, rising geriatric population (as this population segment is more prone to developing cardiovascular disorders), and the rising preference for minimally invasive surgeries.

North America to account for the largest share of the global market in 2018

The inflation devices market is segmented into four major regions, namely North America, Europe, Asia Pacific, and Rest of World. North America accounted for the largest share in 2018. The availability of reimbursements for medical procedures, increasing preference for minimally invasive surgical procedures, and the presence of major market players in the region are the key factors contributing to the market growth in this region.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 - 25%, Tier 2 - 30%, and Tier 3 - 45%
  • By Designation: C-level 26%, Director-level 30%, and Others - 44%
  • By Region: North America - 34%, Europe - 26%, APAC - 23%, and RoW - 17%

The major players in the market include Merit Medical Systems (US), Boston Scientific Corporation (US), Cardinal Health (US), CONMED Corporation (US), Medtronic plc (Ireland), Acclarent Inc. (US), Cook Medical (US), Atrion Corporation (US), Becton, Dickinson and Company (US), Terumo Medical Corporation (Japan),  B. Braun Melsungen AG (US), Olympus Corporation (Japan), Teleflex Incorporated (US), and US Endovascular (US), among others.

Research Coverage

This report studies the inflation devices market based on capacity, display type, application, end user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and the respective countries in these regions.

Key Benefits of Buying the Report

This report focuses on various levels of analysis - industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the inflation devices market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Market Estimation Methodology
2.2.1 Product-Based Market Estimation
2.2.2 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Limitations and Assumptions
2.4.1 Limitations
2.4.2 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Market Overview
4.2 Geographic Analysis: Inflation Device Market, By Display Type and Region
4.3 Geographic Analysis: Market, By Capacity and Region
4.4 Market, By Application
4.5 Geographic Snapshot of the Inflation Device Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Geriatric Population
5.2.1.2 Increasing Preference for Minimally Invasive Surgeries
5.2.1.3 Favorable Reimbursement Scenario for Cardiovascular Procedures
5.2.2 Restraints
5.2.2.1 Availability of Effective Alternative Treatments
5.2.2.2 High Rate of Reprocessing Inflation Devices
5.2.3 Opportunities
5.2.3.1 Emerging Economies Offer High-Growth Potential
5.2.3.2 Rising Awareness About Hospital-Acquired Infections and the Rising Adoption of Disposable Accessories
5.2.4 Challenges
5.2.4.1 Product Recalls
5.2.4.2 Presence of Local Manufacturers and Pricing Pressure
6 Inflation Device Market, By Capacity
6.1 Introduction
6.2 20ml Inflation Devices
6.2.1 Easy Availability of 20ml Inflation Devices and Wide Range of Offerings are Driving the Growth of This Market Segment
6.3 30ml Inflation Devices
6.3.1 30ml Inflation Devices Offer Digital Or Analog Displays
6.4 60ml Inflation Devices
6.4.1 60ml Inflation Devices to Witness Highest Growth During the Forecast Period
7 Inflation Device Market, By Display Type
7.1 Introduction
7.2 Analog Inflation Devices
7.2.1 Analog Inflation Devices Accounted for the Larger Market Share Primarily Due to the Low Cost and Portability Associated With These Devices
7.3 Digital Inflation Devices
7.3.1 High Growth of the Digital Inflation Devices Segment is Attributed to the Advanced Display Patterns and Ease of Use Associated With These Devices
8 Inflation Device Market, By Application
8.1 Introduction
8.2 Interventional Cardiology
8.2.1 Interventional Cardiology Forms the Largest Application Segment of the Inflation Devices Market
8.3 Interventional Radiology
8.3.1 Increasing Prevalence of Cancer to Drive the Adoption of Inflation Devices for This Application Segment
8.4 Peripheral Vascular Procedures
8.4.1 Increasing Prevalence of Target Diseases to Drive the Market for This Application Segment
8.5 Gastroenterological Procedures
8.5.1 Gastroenterological Procedures Segment to Witness the Highest Growth Primarily Due to the Increasing Incidence of Gastrointestinal Diseases Across the Globe
8.6 Urological Procedures
8.6.1 Growing Prevalence of Urological Disorders & Ongoing Technical Advancements in the Field of Minimally Invasive Urological Treatments to Drive Market Growth
8.7 Other Applications
9 Inflation Device Market, By End User
9.1 Introduction
9.2 Hospitals and Clinics
9.2.1 Hospitals Hold the Largest Share of the Market, By End User
9.3 Ambulatory Surgery Centers
9.3.1 Advantages of Ambulatory Care Have Boosted Patient Preference for These Centers
10 Inflation Device Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 US Accounts for the Largest Share of the North American Market
10.2.2 Canada
10.2.2.1 Nearly One-Fifth of the Population Suffers From High Blood Pressure
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Had Among the Highest Obesity Rates in 2017
10.3.2 UK
10.3.2.1 Rising Geriatric Population and Well-Developed Healthcare Infrastructure Account for Market Growth
10.3.3 France
10.3.3.1 Favorable Government Support has Expanded Healthcare Access and Medical Tourism in France
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 China’s Aging Population is Growing at A High Rate
10.4.2 Japan
10.4.2.1 Universal Healthcare Coverage has Allowed for Easy Access to Healthcare in Japan
10.4.3 India
10.4.3.1 High Target Patient Population in India Will Drive Market Growth
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
11 Competitive Landscape
11.1 Introduction
11.2 Market Ranking
11.3 Competitive Scenario
11.3.1 Product Launches and Approvals
11.3.2 Acquisitions
11.3.3 Expansions
11.3.4 Partnerships, Agreements, and Collaborations
11.4 Competitive Leadership Mapping: Major Market Players (2018)
11.4.1 Visionary Leaders
11.4.2 Innovators
11.4.3 Dynamic Differentiators
11.4.4 Emerging Companies
12 Company Profiles
12.1 Advanced Lifesciences Pvt. Ltd.
12.2 Acclarent, Inc. (Subsidiary of Johnson & Johnson)
12.3 Atrion Corporation
12.4 B. Braun Melsungen AG
12.5 Becton, Dickinson and Company
12.6 Boston Scientific Corporation
12.7 Cardinal Health
12.8 Conmed Corporation
12.9 Cook Medical
12.10 Medtronic PLC
12.11 Merit Medical Systems
12.12 Olympus Corporation
12.13 Teleflex Incorporated
12.14 Terumo Medical Corporation
12.15 US Endovascular
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details
List of Tables
Table 1 Comparison of Cardiac Surgical Procedure Prices (Us vs Major Medical Tourism Countries)
Table 2 Inflation Device Market Size, By Capacity, 2017–2024 (USD Million)
Table 3 20ml Market, By Region, 2017–2024 (USD Million)
Table 4 30ml Market, By Region, 2017–2024 (USD Million)
Table 5 60ml Market, By Region, 2017–2024 (USD Million)
Table 6 Market, By Display Type, 2017–2024 (USD Million)
Table 7 Analog Inflation Devices: Market, By Region, 2017–2024 (USD Million)
Table 8 Digital Inflation Devices: Market, By Region, 2017–2024 (USD Million)
Table 9 Market, By Application, 2017–2024 (USD Million)
Table 10 Market for Interventional Cardiology, By Region, 2017–2024 (USD Million)
Table 11 Market for Interventional Radiology, By Region, 2017–2024 (USD Million)
Table 12 Market for Peripheral Vascular Procedures, By Region, 2017–2024 (USD Million)
Table 13 Market for Gastroenterological Procedures, By Region, 2017–2024 (USD Million)
Table 14 Market for Urological Procedures, By Region, 2017–2024 (USD Million)
Table 15 Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 16 Market, By End User, 2017–2024 (USD Million)
Table 17 Market for Hospitals and Clinics, By Region, 2017–2024 (USD Million)
Table 18 Market for Ambulatory Surgery Centers, By Region, 2017–2024 (USD Million)
Table 19 Market, By Region, 2017–2024 (USD Million)
Table 20 North America: Market, By Country, 2017–2024 (USD Million)
Table 21 North America: Market, By Capacity, 2017–2024 (USD Million)
Table 22 North America: Market, By Display Type, 2017–2024 (USD Million)
Table 23 North America: Market, By Application, 2017–2024 (USD Million)
Table 24 North America: Market, By End User, 2017–2024 (USD Million)
Table 25 US: Market, By Capacity, 2017–2024 (USD Million)
Table 26 US: Market, By Display Type, 2017–2024 (USD Million)
Table 27 US: Market, By Application, 2017–2024 (USD Million)
Table 28 US: Market, By End User, 2017–2024 (USD Million)
Table 29 Canada: Market, By Capacity, 2017–2024 (USD Million)
Table 30 Canada: Market, By Display Type, 2017–2024 (USD Million)
Table 31 Canada: Market, By Application, 2017–2024 (USD Million)
Table 32 Canada: Market, By End User, 2017–2024 (USD Million)
Table 33 Europe: Market, By Country, 2017–2024 (USD Million)
Table 34 Europe: Market, By Capacity, 2017–2024 (USD Million)
Table 35 Europe: Market, By Display Type, 2017–2024 (USD Million)
Table 36 Europe: Market, By Application, 2017–2024 (USD Million)
Table 37 Europe: Market, By End User, 2017–2024 (USD Million)
Table 38 Germany: Market, By Capacity, 2017–2024 (USD Million)
Table 39 Germany: Market, By Display Type, 2017–2024 (USD Million)
Table 40 Germany: Market, By Application, 2017–2024 (USD Million)
Table 41 Germany: Market, By End User, 2017–2024 (USD Million)
Table 42 UK: Market, By Capacity, 2017–2024 (USD Million)
Table 43 UK: Market, By Display Type, 2017–2024 (USD Million)
Table 44 UK: Market, By Application, 2017–2024 (USD Million)
Table 45 UK: Market, By End User, 2017–2024 (USD Million)
Table 46 France: Market, By Capacity, 2017–2024 (USD Million)
Table 47 France: Market, By Display Type, 2017–2024 (USD Million)
Table 48 France: Market, By Application, 2017–2024 (USD Million)
Table 49 France: Market, By End User, 2017–2024 (USD Million)
Table 50 Rest of Europe: Market, By Capacity, 2017–2024 (USD Million)
Table 51 Rest of Europe: Market, By Display Type, 2017–2024 (USD Million)
Table 52 Rest of Europe: Market, By Application, 2017–2024 (USD Million)
Table 53 Rest of Europe: Market, By End User, 2017–2024 (USD Million)
Table 54 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 55 Asia Pacific: Market, By Capacity, 2017–2024 (USD Million)
Table 56 Asia Pacific: Market, By Display Type, 2017–2024 (USD Million)
Table 57 Asia Pacific: Market, By Application, 2017–2024 (USD Million)
Table 58 Asia Pacific: Market, By End User, 2017–2024 (USD Million)
Table 59 China: Market, By Capacity, 2017–2024 (USD Million)
Table 60 China: Market, By Display Type, 2017–2024 (USD Million)
Table 61 China: Market, By Application, 2017–2024 (USD Million)
Table 62 China: Market, By End User, 2017–2024 (USD Million)
Table 63 Japan: Market, By Capacity, 2017–2024 (USD Million)
Table 64 Japan: Market, By Display Type, 2017–2024 (USD Million)
Table 65 Japan: Market, By Application, 2017–2024 (USD Million)
Table 66 Japan: Market, By End User, 2017–2024 (USD Million)
Table 67 India: Market, By Capacity, 2017–2024 (USD Million)
Table 68 India: Market, By Display Type, 2017–2024 (USD Million)
Table 69 India: Market, By Application, 2017–2024 (USD Million)
Table 70 India: Market, By End User, 2017–2024 (USD Million)
Table 71 RoAPAC: Market, By Capacity, 2017–2024 (USD Million)
Table 72 RoAPAC: Market, By Display Type, 2017–2024 (USD Million)
Table 73 RoAPAC: Market, By Application, 2017–2024 (USD Million)
Table 74 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 75 RoW: Market, By Capacity, 2017–2024 (USD Million)
Table 76 RoW: Market, By Display Type, 2017–2024 (USD Million)
Table 77 RoW: Market, By Application, 2017–2024 (USD Million)
Table 78 RoW: Market, By End User, 2017–2024 (USD Million)
List of Figures
Figure 1 Inflation Device Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Bottom-Up Approach Market Size Estimation: Market
Figure 4 Top-Down Approach Market Size Estimation: Inflation Devices
Figure 5 Data Triangulation Methodology
Figure 6 Market Share, By Display Type, 2018
Figure 7 Market Share, By Capacity, 2018
Figure 8 Market, By Application, 2019–2024 (USD Million)
Figure 9 Market Share, By End User, 2018
Figure 10 Market, By Region: Geographical Snapshot
Figure 11 Increasing Preference for Minimally Invasive Surgeries is Driving the Growth of Market Across the Globe
Figure 12 Asia Pacific to Grow at the Highest CAGR During the Forecast Period
Figure 13 20ml Inflation Devices Segment Dominated the Asia Pacific Market in 2018
Figure 14 Interventional Cardiology to Hold the Largest Share of the Market During the Forecast Period
Figure 15 Asia Pacific to Register the Highest CAGR During the Forecast Period
Figure 16 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Projected Increase in the Geriatric Population, By Region, 2015 vs 2030
Figure 18 Percutaneous Transluminal Coronary Angioplasty (PTCA) Surgical Procedures Performed in Key European Countries, 2011 vs 2016 (Per 100,000 Inhabitants)
Figure 19 Cost of Angioplasty Across Major Countries, 2016
Figure 20 20ml Segment is Expected to Hold the Largest Share of the Market During the Forecast Period
Figure 21 Analog Inflation Devices Segment Will Continue to Dominate the Market During the Forecast Period
Figure 22 Gastroenterological Procedures Segment to Witness the Highest Growth in the Inflation Devices Market During the Forecast Period
Figure 23 Hospitals & Clinics Segment to Hold the Largest Share of the Market During the Forecast Period
Figure 24 Geographic Snapshot of the Market
Figure 25 North America: Market Snapshot
Figure 26 Asia Pacific: Inflation Devices Market Snapshot
Figure 27 Inflation Devices Market Ranking, By Key Player, 2018
Figure 28 Vendor Dive: Evaluation Overview
Figure 29 Johnson & Johnson: Company Snapshot
Figure 30 Atrion Corporation: Company Snapshot
Figure 31 B. Braun Melsungen AG: Company Snapshot
Figure 32 BD: Company Snapshot
Figure 33 Boston Scientific Corporation: Company Snapshot
Figure 34 Cardinal Health: Company Snapshot
Figure 35 Conmed Corporation: Company Snapshot
Figure 36 Medtronic: Company Snapshot
Figure 37 Merit Medical Systems: Company Snapshot
Figure 38 Olympus Corporation: Company Snapshot
Figure 39 Teleflex Incorporated: Company Snapshot
Figure 40 Terumo Corporation: Company Snapshot

Executive Summary

Companies Mentioned

  • Acclarent, Inc. (Subsidiary of Johnson & Johnson)
  • Advanced Lifesciences Pvt. Ltd.
  • Atrion Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health
  • Conmed Corporation
  • Cook Medical
  • Medtronic PLC
  • Merit Medical Systems
  • Olympus Corporation
  • Teleflex Incorporated
  • Terumo Medical Corporation
  • US Endovascular

Table Information